Chronic pulmonary aspergillosis (CPA) is slowly progressive inflammatory pulmonary syndrome
due to Aspergillus spp. The evidence regarding CPA treatment is limited. We conducted …

We compared the specificities and sensitivities of four tests used for the serodiagnosis of
candidemia in 39 patients with candidemia, including 10 patients with superficial Candida …

Although the diagnostic significance of isolating Aspergillus spp. from respiratory cultures
has been studied in immunocompromised hosts with invasive pulmonary aspergillosis (IPA), …

Background In vitro drug screening studies have indicated that camostat mesilate (FOY-305)
may prevent SARS-CoV-2 infection into human airway epithelial cells. This study was …

This is the first report of a detailed relationship between triazole treatment history and triazole
MICs for 154 Aspergillus fumigatus clinical isolates. The duration of itraconazole dosage …

We investigated the triazole, amphotericin B, and micafungin susceptibilities of 196 A.
fumigatus clinical isolates in Nagasaki, Japan. The percentages of non-wild-type (non-WT) …

Background Macrolides have antibiotic and immunomodulatory activities, which may have a
favorable effect on the clinical outcome of patients with infections, including influenza. This …

Objective To clarify the clinical features of pulmonary cryptococcosis in Japanese non-HIV
population. Methods Retrospective investigation of 151 pulmonary cryptococcosis cases …

A Candida glabrata calcineurin mutant exhibited increased susceptibility to both azole
antifungal and cell wall-damaging agents and was also attenuated in virulence. Although a …

Diagnosing chronic pulmonary aspergillosis (CPA) is complicated, and there are limited data
available regarding the identification of galactomannan (GM) in clinical specimens to assist …